Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 10/31/21
End: 01/31/23
Due: 01/31/24
Phase: N/A
Priority: Normal
Start: 12/15/22
End: 10/31/25
Due: 10/31/26
Phase: N/A
Priority: Normal
Start: 11/05/22
End: 10/31/25
Due: 10/31/26
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Effect of Levosimendan on Left Ventricular Systolic Function and Heart Failure After PCI in Patients With Acute Anterior Myocardial Infarction | NCT04970238 | Zhijun Sun | user2@example.com | None | 2021-10-31 | 2023-01-31 | 2024-01-31 | - | - | 2025-07-14 |
| EMPAGUM: Effects of Empagliflozin on Gut Microbiota in Heart Failure With a Preserved Ejection Fraction | NCT05584319 | Zhijun Sun | user2@example.com | None | 2022-12-15 | 2025-10-31 | 2026-10-31 | - | - | 2025-07-14 |
| Empagliflozin on the Function of Left Atrium in Heart Failure With Mildly Reduced or Preserved Ejection Fraction | NCT05600387 | Zhijun Sun | user2@example.com | None | 2022-11-05 | 2025-10-31 | 2026-10-31 | - | - | 2025-07-14 |